The Urinalysis Market in North America is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. The urinalysis market is characterized by the presence of various small and big companies. The market players are adopting the strategies such as new product launches, regional expansions, and technological advancements to expand their market share. Rising demand for rapid tests, point-of-care (PoC) testing, and portable instruments are encouraging new product launches in the urinalysis market. The PoC testing enables rapid results in non-laboratory settings, along with boosting productivity. These tests are cost-effective and encompass the diagnoses of a wide range of diseases. Moreover, the growing demand for PoC diagnostics products is further driving product innovations in the urinalysis market. Market players are readily investing in R&D to develop advanced technologies.
North America Urinalysis Market Segmentation
North America Urinalysis Market –
By Product
- Consumables
- Instruments
North America Urinalysis Market – By
Test Type
- Pregnancy and Fertility Tests
- Biochemical Urinalysis
- Sediment Urinalysis
North America Urinalysis Market – By Application
- Disease Screening
- Pregnancy and Fertility
North America Urinalysis Market – By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Research Laboratories and Institutes
North America Urinalysis Market – By Country
- US
- Canada
- Mexico
North America Urinalysis Market – Company Profiles
- Abbott
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- Cardinal Health Inc
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Siemens Healthineers AG
- Sysmex Corporation
North America Urinalysis Market Overview
The North American urinalysis market, dominated by the United States, is experiencing robust growth driven by several key factors. Increased prevalence of chronic diseases, significant investments in research and development, and rising public healthcare expenditure are all contributing to the market’s expansion. Furthermore, growing awareness of preventative healthcare through public health initiatives is boosting demand for urinalysis.
The COVID-19 pandemic initially disrupted the market, as lockdowns led to delays in routine health checkups and a temporary decrease in testing volumes. However, the pandemic also highlighted the critical role of urinalysis in managing COVID-19 related complications. Notably, COVID-19 patients, particularly those with acute kidney injury (AKI), require ongoing urinalysis monitoring due to the increased risk of chronic kidney disease. This has led to a resurgence in testing and a renewed focus on the importance of urinalysis in post-COVID-19 care. Regulatory bodies also accelerated diagnostic product approvals during the pandemic, and companies adapted by introducing COVID-19 rapid tests and forging strategic partnerships, such as Sysmex America’s agreement with Siemens Healthineers to expand distribution of automated urine chemistry analyzers. As vaccination programs progress and transmission rates decline, the healthcare system is expected to normalize, driving significant long-term demand for urinalysis products and services.
Strategic Insights for the North America Urinalysis Market
To thrive in the dynamic North American urinalysis market, stakeholders need data-driven strategic insights. This analysis provides a comprehensive view of current trends, key players, and regional variations, enabling informed decision-making. By identifying untapped market segments and developing unique value propositions, businesses can differentiate themselves from competitors.
Leveraging advanced data analytics is crucial for anticipating market shifts and adapting to evolving needs. Whether you are an investor, manufacturer, or healthcare provider, these insights offer actionable recommendations for long-term success. A forward-looking perspective is essential for navigating the changing landscape and positioning your organization for sustainable growth. Ultimately, these strategic insights empower you to make informed decisions that drive profitability and achieve your business objectives in the North American urinalysis market.
Other Reports:
North America Multiple Sclerosis Therapeutics Market: https://www.quora.com/profile/Business-Market-Insights-1/North-America-Multiple-Sclerosis-Therapeutics-Market-2027-Size-Share-Industry-Trends-Business-Revenue-Forecast-and-S
North America Artificial Intelligence in Market: https://penzu.com/p/6a525833f613cd65
North America Long Read Sequencing Market: https://postyourarticle.com/north-america-long-read-sequencing-market-analysis-trends-share-development-policies-and-future-growth-2028/
North America Stevia Market: https://sites.google.com/view/north-america-long-read-sequen/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
